Tango Therapeutics Inc. (TNGX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-08-20
4:31 pm
Purchase
2021-08-1013DTango Therapeutics, Inc.
TNGX
BCTG Holdings, LLC6,988,450
8.300%
6,988,450increase
(New Position)
Filing
History
2021-08-19
4:59 pm
Purchase
2021-08-1013GTango Therapeutics, Inc.
TNGX
Casdin Capital LLC5,487,910
6.300%
5,487,910increase
(New Position)
Filing
History
2021-08-19
4:35 pm
Purchase
2021-08-1013DTango Therapeutics, Inc.
TNGX
Third Rock Ventures IV, L.P.19,363,975
22.100%
19,363,975increase
(New Position)
Filing
History
2021-04-26
4:30 pm
Purchase
2021-04-1413GBCTG Acquisition Corp.
BCTG
Southpoint Capital Advisors LP1,906,380
8.900%
1,906,380increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GBCTG Acquisition Corp.
BCTG
RA CAPITAL MANAGEMENT L.P.1,250,000
5.800%
1,250,000increase
(New Position)
Filing
History
2021-02-16
4:35 pm
Purchase
2020-12-3113GBCTG Acquisition Corp.
BCTG
BCTG Holdings, LLC4,488,450
21.000%
4,488,450increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2